Jaysynth Orgochem Limited reported a sharp rise in profitability for the quarter ended June 30, 2026, with standalone net profit after tax jumping 188% year-on-year to ₹534.86 lakh from ₹185.94 lakh in Q1FY26. Consolidated net profit surged 220% to ₹550.04 lakh against ₹171.80 lakh in the prior year period. The results reflect improved operational efficiency and higher income from operations, signaling a strong start to FY27 for the colorants and chemicals manufacturer.

The Board of Directors, meeting on August 5, 2026, approved the un-audited financial results which were reviewed by the Audit Committee and subjected to a limited review by the Statutory Auditor as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results comply with Ind AS prescribed under Section 133 of the Companies Act, 2013.

Financial Performance

Standalone total income from operations stood at ₹5,878.93 lakh, up slightly from ₹5,777.17 lakh in Q1FY26 but down from ₹6,692.53 lakh in Q4FY26. Consolidated revenue was ₹5,812.86 lakh, compared to ₹5,900.84 lakh in the corresponding quarter last year. Earnings per share (basic) increased to ₹0.40 from ₹0.14 on a standalone basis.

Corporate Developments

The company incorporated a wholly owned subsidiary, VarnaTex Limited, in Hong Kong on July 17, 2026, with a proposed subscription capital of 5,00,000 HKD. As of the reporting date, share allotment and capital transfer were pending, and operations had not commenced; thus, this event had no financial impact on Q1FY27 results.

Based on the Audit Committee’s recommendation, the Board appointed M/s. Chhognmal & Co., Chartered Accountants (FRN: 101826W), as Statutory Auditors for a term of five consecutive years, commencing from the conclusion of the 52nd Annual General Meeting until the 57th AGM, subject to member approval. The outgoing auditors, M/s. AHJ & Associates, will complete their term at the 52nd AGM.

What the Numbers Show

The disproportionate rise in net profit relative to stable revenue indicates significant margin expansion or cost control improvements in Q1FY27. While standalone revenue grew marginally by 1.8% YoY, net profit nearly tripled, suggesting that operational leverage played a key role in driving bottom-line growth rather than top-line volume expansion.

Jaysynth Orgochem Limited appointed M/s. Chhogmal & Co., Chartered Accountants (FRN: 101826W), as its statutory auditors for a term of five consecutive years. The Board of Directors approved the appointment on August 5, 2026, based on the recommendation of the Audit Committee. The new tenure will commence from the conclusion of the 52nd Annual General Meeting and continue until the conclusion of the 57th Annual General Meeting, subject to shareholder approval.

The Mumbai-based chemical manufacturer made this disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The outgoing statutory auditors, M/s. A H J & Associates (FRN: 151685W), will complete their tenure at the end of the 52nd AGM.

Auditor Profile and Transition

M/s. Chhogmal & Co. is a prominent Mumbai-based chartered accountancy firm established in 1965. Led by Managing Partner Chintan N. Shah, the firm provides specialized corporate services including Audit & Assurance, Direct & Indirect Taxation, and FEMA & Business Advisory. The firm serves major corporate clients and listed entities, including Supreme Industries, Yash Optics & Lens, Citibank NA, and Axis Bank.

The transition follows the company’s strong financial performance in Q1FY27, where standalone net profit rose 188% to ₹5.35 crore. The Board also approved the unaudited standalone and consolidated financial results on August 5, 2026, which were reviewed by the outgoing auditors.

Corporate Governance Context

The appointment ensures continuity in audit oversight during a period of operational expansion. Jaysynth Orgochem recently incorporated a wholly-owned subsidiary, VarnaTex Limited, in Hong Kong on July 17, 2026. As of the reporting date, share allotment and capital transfer for the subsidiary are pending, resulting in no financial impact for Q1FY27.

What the Numbers Show

The decision to appoint a long-standing, established firm like Chhogmal & Co. signals a focus on robust compliance and audit quality as the company navigates international expansions. With the Inkjet Printers segment continuing to incur losses while the Colorants & Chemicals segment drives profitability, rigorous independent oversight becomes critical for accurate segment reporting and margin analysis.